Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3.

Spindler V, Drenckhahn D, Zillikens D, Waschke J.

Am J Pathol. 2007 Sep;171(3):906-16.

2.

Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.

Femiano F.

Minerva Stomatol. 2007 Apr;56(4):215-23. Review. English, Italian.

3.

Pemphigus foliaceus.

Dasher D, Rubenstein D, Diaz LA.

Curr Dir Autoimmun. 2008;10:182-94. doi: 10.1159/000131454. Review.

PMID:
18460886
4.

Pemphigus: a complex T cell-dependent autoimmune disorder leading to acantholysis.

Veldman C, Feliciani C.

Clin Rev Allergy Immunol. 2008 Jun;34(3):313-20. Review.

PMID:
18097775
5.

Defective cell-cell adhesion in the epidermis.

Stanley JR.

Ciba Found Symp. 1995;189:107-20; discussion 120-3, 174-6. Review.

PMID:
7587627
6.

Immune dysregulation of pemphigus in humans and mice.

Yokoyama T, Amagai M.

J Dermatol. 2010 Mar;37(3):205-13. doi: 10.1111/j.1346-8138.2009.00797.x. Review.

PMID:
20507383
7.

Apoptosis in pemphigus.

Schmidt E, Waschke J.

Autoimmun Rev. 2009 Jun;8(7):533-7. doi: 10.1016/j.autrev.2009.01.011. Review.

PMID:
19189866
8.

IgG/IgA pemphigus with IgG and IgA antidesmoglein 1 antibodies detected by enzyme-linked immunosorbent assay.

Oiso N, Yamashita C, Yoshioka K, Amagai M, Komai A, Nagata Y, Hashimoto T, Ishii M.

Br J Dermatol. 2002 Nov;147(5):1012-7. Review.

PMID:
12410717
9.

Immunoadsorption in pemphigus.

Eming R, Hertl M.

Autoimmunity. 2006 Nov;39(7):609-16. Review.

PMID:
17101505
10.

Pemphigus vulgaris and its active disease mouse model.

Amagai M.

Curr Dir Autoimmun. 2008;10:167-81. doi: 10.1159/000131453. Review.

PMID:
18460885
11.

Desmoglein autoimmunity in the pathogenesis of pemphigus.

Gniadecki R.

Autoimmunity. 2006 Nov;39(7):541-7. Review.

PMID:
17101497
12.

Beyond steric hindrance: the role of adhesion signaling pathways in the pathogenesis of pemphigus.

Sharma P, Mao X, Payne AS.

J Dermatol Sci. 2007 Oct;48(1):1-14. Review.

PMID:
17574391
13.

Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris.

Koga H, Tsuruta D, Ohyama B, Ishii N, Hamada T, Ohata C, Furumura M, Hashimoto T.

Expert Opin Ther Targets. 2013 Mar;17(3):293-306. doi: 10.1517/14728222.2013.744823. Review.

PMID:
23294403
14.

Non-pathogenic anti-desmoglein 3 IgG autoantibodies in Fogo Selvagem.

Amagai M.

J Invest Dermatol. 2006 Sep;126(9):1931-2. Review.

15.

Diagnosis and clinical features of pemphigus vulgaris.

Venugopal SS, Murrell DF.

Immunol Allergy Clin North Am. 2012 May;32(2):233-43, v-vi. doi: 10.1016/j.iac.2012.04.003. Review.

PMID:
22560136
16.

Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity.

Culton DA, Qian Y, Li N, Rubenstein D, Aoki V, Filhio GH, Rivitti EA, Diaz LA.

J Autoimmun. 2008 Dec;31(4):311-24. doi: 10.1016/j.jaut.2008.08.003. Review.

17.

Role of Rho GTPases in desmosomal adhesion and pemphigus pathogenesis.

Spindler V, Waschke J.

Ann Anat. 2011 May;193(3):177-80. doi: 10.1016/j.aanat.2011.02.003. Review.

PMID:
21441018
18.

Desmoglein as a target in skin disease and beyond.

Amagai M, Stanley JR.

J Invest Dermatol. 2012 Mar;132(3 Pt 2):776-84. doi: 10.1038/jid.2011.390. Review.

19.

Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris.

Amber KT, Staropoli P, Shiman MI, Elgart GW, Hertl M.

Exp Dermatol. 2013 Nov;22(11):699-704. doi: 10.1111/exd.12229. Review.

PMID:
24433179
20.

Immune cellular regulation on autoantibody production in pemphigus.

Pan M, Zhu H, Xu R.

J Dermatol. 2015 Jan;42(1):11-7. doi: 10.1111/1346-8138.12697. Review.

PMID:
25558947

Supplemental Content

Support Center